Yes, if I am treating triple positive, I generally add ET to HP regardless of whether the patient received THP or not. The therapeutic window is wide, and likelihood of cross-talk interfering with long-term anti-HER2 effectiveness is high. While not tested systematically, HP alone is likely a r...